These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6801857)

  • 41. The potential role of immunosuppression, plasmapheresis, and desensitization as treatment modalities for Rh immunization.
    Caudle MR; Scott JR
    Clin Obstet Gynecol; 1982 Jun; 25(2):313-9. PubMed ID: 6179680
    [No Abstract]   [Full Text] [Related]  

  • 42. [Hemolytic disease of the newborn due to rhesus incompatibility].
    von Criegern T
    Med Klin; 1979 Jun; 74(26):1013-22. PubMed ID: 111015
    [No Abstract]   [Full Text] [Related]  

  • 43. Controlled trial of various anti-D dosages in suppression of Rh sensitization following pregnancy. Report to the Medical Research Council by the working party on the use of anti-D-immunoglobulin for the prevention of isoimmunization of Rh-negative women during pregnancy.
    Br Med J; 1974 Apr; 2(5910):75-80. PubMed ID: 4207590
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rhesus immunisation during pregnancy: the case for antenatal anti-D.
    Clarke C; Whitfield AG
    Br Med J; 1980 Mar; 280(6218):903-4. PubMed ID: 6770941
    [No Abstract]   [Full Text] [Related]  

  • 45. Dose of rhesus immunoprophylaxis.
    Tabor A; Bock JE; Jerne D; Jacobsen JC
    Lancet; 1983 Jan; 1(8316):121. PubMed ID: 6129430
    [No Abstract]   [Full Text] [Related]  

  • 46. Twin pregnancy complicated by severe hemolytic disease of the fetus and newborn due to anti-g and anti-C.
    Trevett TN; Moise KJ
    Obstet Gynecol; 2005 Nov; 106(5 Pt 2):1178-80. PubMed ID: 16260562
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Successful treatment of severe rhesus D-incompatible pregnancy with repeated double-filtration plasmapheresis.
    Kamei K; Yamaguchi K; Sato M; Ogura M; Ito S; Okada T; Wada S; Sago H
    J Clin Apher; 2015 Oct; 30(5):305-7. PubMed ID: 25413689
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transfusion support in the management of immune haemolytic disorders.
    Plapp FV; Beck ML
    Clin Haematol; 1984 Feb; 13(1):167-83. PubMed ID: 6327130
    [No Abstract]   [Full Text] [Related]  

  • 49. [Current viewpoints in the anti-D prevention of rhesus alloimmunization in the pregnant woman and of hemolytic disease of the newborn infant (a review of the literature)].
    Spasova K; Vŭlcheva B
    Akush Ginekol (Sofiia); 1986; 25(3):84-90. PubMed ID: 3019168
    [No Abstract]   [Full Text] [Related]  

  • 50. A quantitative assay for subclassing IgG alloantibodies implicated in hemolytic disease of the newborn.
    Thomas NC; Shirey RS; Blakemore K; Kickler TS
    Vox Sang; 1995; 69(2):120-5. PubMed ID: 8585192
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Haemolytic disease of the newborn due to antibodies other than rhesus anti-D.
    Br Med J (Clin Res Ed); 1981 Aug; 283(6290):514-5. PubMed ID: 6790046
    [No Abstract]   [Full Text] [Related]  

  • 52. Rh immunoglobulin in prevention of hemolytic disease of newborn child.
    Gorman JG
    N Y State J Med; 1983 Jan; 83(1):42-9. PubMed ID: 6402737
    [No Abstract]   [Full Text] [Related]  

  • 53. [Severe anti-D allo-immunization: failure of repeated antenatal plasmapheresis (a case report)].
    Herve P; Coffe C; Lapprand L; Peters A; Selva J; Gillet JY
    Nouv Presse Med; 1978 Jun; 7(22):1956-7. PubMed ID: 97627
    [No Abstract]   [Full Text] [Related]  

  • 54. Protection against Rh D-haemolytic disease of the newborn by a diminished transport of maternal IgG to the fetus.
    Dooren MC; Engelfriet CP
    Vox Sang; 1993; 65(1):59-61. PubMed ID: 8362516
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Perinatal mortality from Rh(D) hemolytic disease in Finland, 1975-1984.
    Eklund J; Nevanlinna HR
    Acta Obstet Gynecol Scand; 1986; 65(7):787-9. PubMed ID: 3028031
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An autoanalyzer test to determine immunoglobulin class and IgG subclass of blood group antibodies.
    Szymanski IO; Huff SR; Delsignore R
    Transfusion; 1982; 22(2):90-5. PubMed ID: 6803411
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sound boards. Rh immunoprophylaxis: is antepartum therapy desirable?
    Nusbacher J; Bove JR
    N Engl J Med; 1980 Oct; 303(16):935-7. PubMed ID: 6774249
    [No Abstract]   [Full Text] [Related]  

  • 58. Non-"D" rhesus and irregular antibodies--an approach to management.
    Dornan KJ
    Ir Med J; 1982 Mar; 75(3):79-82. PubMed ID: 6804410
    [No Abstract]   [Full Text] [Related]  

  • 59. [Initial trials in the treatment of feto-maternal alloimmunization in the Rhesus system with oral administration of erythrocyte antigens].
    Parinaud J; Fournié A; Grandjean H; Blanc M; Pontonnier G
    J Gynecol Obstet Biol Reprod (Paris); 1983; 12(4):407-13. PubMed ID: 6415152
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Blocked D phenomenon, a rare condition with Rh D haemolytic disease of newborn - a case report.
    Sulochana PV; Rajesh A; Mathai J; Sathyabhama S
    Int J Lab Hematol; 2008 Jun; 30(3):244-7. PubMed ID: 18205842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.